Article ID Journal Published Year Pages File Type
3977177 Brachytherapy 2011 4 Pages PDF
Abstract
Intraoral mold-based HDR brachytherapy can be used to treat tumors involving the maxillary antrum provided that access is possible through a previous maxillectomy. A dose reduction of 4-43% in several OARs, such as the spinal cord, pituitary gland, optic chiasm, optic nerve, eyeball, and lens, is obtained.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
Use of customized-mold brachytherapy in the management of malignancies arising in the maxillary antrum after maxillectomy: A dosimetric analysis
Authors
, , , , ,